⚕️ Diagnostic Imaging

Near-Passive Vision Into the Body — Without Harmful Radiation

Replacing MRI, CT, and ultrasound with a single device. No radiation, no magnets, no helium. Near-molecular precision — from an office chair.

0
Radiation
0
Helium
~5nm
Step Precision
Repeat Scans

Offner Technologies is developing a radiation-free diagnostic imaging device using Non-Linear Standing Wave Interferometry (NL-SWI). The device uses harmless acoustic waves to achieve near-molecular precision — independent of wave frequency. It is designed to replace the capabilities of MRI, CT, and conventional ultrasound in a single device, without radiation, magnets, helium, contrast agents, or dedicated infrastructure. Extended viewing without time limits, repeat scans without radiation dose calculations, and the ability to operate like a virtual catheter — penetrating tissues, body cavities, and arterial plaques from outside the body.

Every Existing Imaging System Demands a Compromise

🧲

MRI

Excellent soft-tissue contrast — but requires 1,500–2,000 litres of liquid helium, a shielded room, and costs $1–3M per system. Helium prices have doubled since 2019. Additionally, MRI generates tissue heating (SAR) — raising body temperature with potential risk to protein stability, limiting scan duration and power levels.

☢️

CT

Fast, high-resolution structural imaging — but delivers ionizing radiation. Cumulative exposure limits repeat scanning. Not suitable for continuous monitoring.

🔊

Ultrasound

Safe and affordable — but resolution is fundamentally limited by wavelength. Higher frequencies give better detail but cannot penetrate deep tissue or bone.

What If Precision Had Nothing to Do with Frequency?

The company's core scientific advance is the ability to decouple measurement precision from wave frequency. The technology measures acoustic wavefronts with extraordinary precision, which means the optimal frequency can be chosen for each clinical task — maximizing penetration depth — without sacrificing resolution. Conventional systems must compromise between frequency (resolution) and penetration.

Frequency Selected by Clinical Need, Not Resolution Need

Need to image through the skull? The device uses approximately 200 KHz — a frequency that penetrates bone easily — while still achieving sub-millimetre precision. Need to measure structures in the eye? It uses approximately 5 MHz for optimal interaction with ocular tissue. In every case, precision comes from the measurement method, not from the frequency.

The same underlying physics — ultrasonic phase measurement at sub-micron resolution — has been independently demonstrated by others in different fields, including research at NASA Langley Research Center (Haldren et al., Rev. Sci. Instrum. 89, 054902, 2018).

The technology earned 26 patents in its older generation — which demonstrates the strength of the underlying physics. Offner has developed a new approach that enables more advanced use of the technology and precise control of its characteristics. The result is a fully computer-controlled system that could not have been developed without the assistance of artificial intelligence.

Clinical Capabilities from a Single Device

🧠

Non-Invasive Brain Visualization

See neural structures without radiation or contrast agents. Low-frequency acoustic waves penetrate the skull while maintaining sub-millimetre precision.

🫀

Virtual Catheterization

The system can operate like a virtual catheter — penetrating tissues, body cavities, arterial plaques, and identifying tissue structure at a level of detail not previously possible.

🔬

Early Tumour Detection

Detect what MRI and CT may miss, before symptoms appear. Acoustic resonance reveals tissue boundaries invisible to conventional amplitude-based imaging.

🔄

Unlimited Patient Monitoring

Zero radiation means no exposure limits. Monitor patients continuously, repeat scans as often as needed, track treatment progress in real time.

🩺

Real-Time Tissue Characterization

Identify tissue abnormalities at the cellular level through acoustic signatures. Different tissues produce distinct response patterns — enabling characterization without biopsy.

📐

No Specialist Required

The system is designed to be so refined that it reduces dependence on specialist-only diagnoses — continuous viewing with focus control, even while the patient sits in an office chair.

One Device vs. Three Separate Systems

Feature MRI CT Ultrasound NL-SWI Imager
Ionizing RadiationNoneYesNoneNone
Requires Helium1,500–2,000 LNoNoNo
Dedicated FacilityShielded roomSpecialized suitePortablePortable
Deep Tissue + High ResolutionGood contrast, limited resolutionGood structure, radiation costMust sacrifice oneBoth — decoupled
Tissue Heating (SAR)Yes — limits durationMinimalNegligibleNone
Unlimited Repeat ScansSafe but expensiveRadiation limitsYesYes
Continuous MonitoringNoNoLimited depthYes
System Cost$1–3M$0.5–2M$20–200KComparable to US

A $50–65 Billion Market Facing Structural Pressure

The diagnostic imaging industry faces converging pressures that make alternative approaches increasingly urgent.

The helium crisis — MRI systems depend on liquid helium for superconducting magnets. Helium prices have doubled since 2019. The US Federal Helium Reserve was sold in 2024, putting 30% of US supply at risk.

The access gap — rural hospitals cannot afford MRI installation. Developing countries have entire regions without advanced imaging. Emergency patients must be transported to imaging suites, losing critical time.

Radiation safety — growing awareness of cumulative radiation exposure is driving demand for non-ionizing alternatives, particularly for pediatric patients, pregnant women, and conditions requiring frequent monitoring.

Tissue heating — MRI generates radiofrequency energy that raises body temperature (SAR — Specific Absorption Rate), with potential risk to protein stability. This limits scan duration, power levels, and the ability to monitor patients continuously.

A portable, radiation-free device with near-molecular precision addresses all three pressures simultaneously.

Frequently Asked Questions

How can an acoustic device achieve imaging quality comparable to MRI or CT?
The technology measures acoustic wavefronts with extraordinary precision, which decouples measurement accuracy from operating frequency. This means the optimal frequency can be chosen for each clinical task — maximizing penetration depth — without sacrificing resolution. Conventional systems must compromise between frequency (resolution) and penetration.
Is this device safe for unlimited repeated scans?
The device uses only acoustic waves at safe diagnostic power levels — no ionizing radiation, no magnetic fields, no contrast agents, and no tissue heating (unlike MRI, which generates radiofrequency energy that raises body temperature). There is no known biological harm from the acoustic energy used, which means there are no theoretical limits on scan frequency or duration. A patient could be monitored continuously.
What is the difference between this and conventional ultrasound?
Conventional ultrasound resolution is limited by wavelength — higher resolution requires higher frequency, which reduces penetration depth. The NL-SWI approach decouples precision from frequency through proprietary wavefront measurement, achieving sub-millimetre accuracy even at low frequencies that penetrate deep tissue and bone. The result is imaging detail far beyond what conventional ultrasound can provide.
Does this device require helium or dedicated infrastructure?
No. Unlike MRI systems that require 1,500–2,000 litres of liquid helium and dedicated shielded rooms, this device is fully portable and operates without cryogenics, shielding, or specialized infrastructure. It can function in a standard clinical room, a field hospital, or a rural clinic.
What clinical applications does the imager target?
Target applications include non-invasive brain visualization without radiation or contrast, virtual catheterization — imaging tissues and body cavities from outside the body, early tumour detection at stages difficult for MRI and CT, real-time tissue characterization at the cellular level, and unlimited patient monitoring without exposure limits.
What is the current development status?
The device is currently in advanced development. The technology earned 26 patents in its older generation — which demonstrates the strength of the underlying physics. Offner has developed a new approach using a fully computer-controlled system developed with the assistance of artificial intelligence. The company is seeking strategic partners for clinical validation and commercialization.

Seeking a Strategic Partner for Clinical Validation

Offner Technologies is a company that knows how to invent. The ideal partner brings diagnostic imaging expertise, regulatory experience, and global distribution. If you can take a validated measurement platform and turn it into a clinical product — let's talk.

Start a Conversation →